Ren Delin
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| VIVA BIOTECH HOLDINGS | 01873 | 01-Dec-23 | ED | |||
| VIVA BIOTECH HOLDINGS | 01873 | 03-Jul-18 | 01-Dec-23 | Pres | The change in executive responsibilities will enable Mr. Ren to focus more of his attention to leading the Group’s CRO and drug discovery businesses. |